Tablets for normalization of sight Okyuvayt Lyutein Forte 3 blisters on 10 pieces

Dietary additive to a diet with vitamins, minerals and carotinoids for improvement of visual acuity.

TM of Okyuvayt - No. 1 in the Vitamins 2018 for Eyes nomination in a competition of consumer preferences "The choice of year" in Ukraine.

Active components

Tablet "Окювайт® Lutein Forte": antioxidant vitamins (vitamin C and E), minerals (zinc and selenium), lutein and zeaxanthin.

Lutein and zeaxanthin are carotinoids - it is the pigments of yellow and hot color which are contained in fruits and vegetables, especially in dark green sheet vegetables as, for example, spinach. High level of carotinoids in "makul", parts of an eye which is responsible for the central sight and the highest visual acuity work as the blue light filter - is similar internal sunglasses - protect eyes from harmful effects of a blue part of a light spectrum.

Carotinoids (lutein and zeaxanthin), vitamins (With and E), minerals (zinc and selenium) are key elements of a system of protection of eyes against oxidatic damage.

Carotinoids, vitamins and minerals which are a part of "Okyuvayt®" directly cannot be made by a human body. They can be received from food or at the use of dietary additives.

Feature

"Okyuvayt® Lyutein forte" can be applied at a disorder of vision at patients with diabetes and also at people, with intolerance of gluten and the patient with a Gee's disease. Does not contain lactose, peanut butter and GMO.

Advantage

Okyuvayt® Lutein forte:

• promotes improvement of visual acuity;
• protects eyes from a harmful range of sunlight and radiation of modern devices;
• is strong antioxidant;
• proved efficiency within 12 years in 4 international researches;
• 16 years in the market of Ukraine - consumer confidence.

"Okyuvayt® Lyutein forte" can be used by

as an additional source of vitamins C, E, zinc, selenium, carotinoids, antioxidants for the purpose of creation of optimal nutritional conditions for ensuring normal functions of sight, improvement of sharpness, optimization of number of free radicals.

Feature of application

Individual intolerance of components. Before the use the consultation of the doctor is recommended.

Adult to accept

on 1-2 tablets a day at meal time, washing down with water.

Structure

One tablet weighing 0.645 g (g) contains the carotinoids received from marigold of 6.5 mg (mg): lutein - 6 mg (mg) and zeaxanthin - 0.5 mg (mg) vitamin C (ascorbic acid) - 60 mg (mg) vitamin E (a DL alpha tocopheryl acetate) - 8.8 mg (mg) selenium (selenic yeast) - 20 mkg (μg) zinc - 5 mg (mg) excipients: silicon dioxide (E 551), ascorbyl palmitate (E 304), mix of tokoferol (E 306), ethyl cellulose (E 462), microcrystalline cellulose (E 460), silicon dioxide (E 551), magnesium stearate (E 572), air of starch, hydroksipropilmetiltsellyuloz (E 464), stearic acid (E 570), titanium dioxide (E 171), ferrous oxide red (E172), Riboflavinum (E 101).

Reference.

1. Окювайт® Lutein forte. Dietary additive to a food allowance. Is not medicine. Full information of cm in a leaf inserts to application of the Okyuvayt® product Lutein forte.

2. Age Related Eye Disease Study Group A randomized, placebo controlled, clinical trial of high dose supplementation with vitamins C and E, beta carotene, and zinc for age related macular degeneration and vision loss AREDS Report No 8 Arch//Ophthalmol. – 2001. – V. 119. – P. 1417–1436.

3. N.A. Ermakova. A role of nutritsevtik in reduction of risk of progressing. age macular dystrophy//Ophthalmology. – No. 13 (3). – 2016. – Page 163-168.

4. E.O. Saksonova. Lutein and zeaxanthin main components of an antioxidant system of protection of an eye//RMZh No. 2. – 2005. – C. 124–128.

5. According to the system of a research of the PharmXplorer Pharmstandart market of the Proxima Research company date of entry into the market of 04.2005 g

6. E.A. Egorov. Some aspects of pathogenesis and treatment of age macular degeneration//RMZh No. 1. – 2016. – C. 46–49.

7. AREDS (2001, 3640 people) and AREDS2 (2013, 4203 people): the substance further used for production Okyuvayt® is provided by the Bausch+Lomb company within the R&D program; LUNA: 2007, the 136th persons, duration of reception of Okyuvayt® up to 24 weeks; CARMA: 2009, the 433rd persons, duration of reception of Okyuvayt® up to 36 months; on the basis of results of researches the extensive meta-analysis is made.